| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Pyridinium, 4-carboxy-1-[(4-carboxyphenyl)methyl]-, bromide (1:1) |
|
1451254-94-6 |
详细
|
| 1,4-Benzenedicarboxylic acid, 2,5-bis[[[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methoxy]carbonyl]amino]-, 1,4-diethyl ester |
1,4-二乙基2,5-双[[[[4-(4,4,5,5-四甲基-1,3,2-二氧硼杂硼烷-2-基)苯基]甲氧基]羰基]氨基]-1, 4-苯二甲酸 |
1609956-75-3 |
详细
|
| Z-VAD-FMK |
氟甲基酮 |
187389-52-2 |
详细
|
| 2-methoxy-N,N-bis(2-methoxyethyl)ethanamine |
|
3235-51-6 |
详细
|
| 1,4-dimethyl-1,4-diazabicyclo[2.2.2]octane-1,4-diium bromide |
|
5450-74-8 |
详细
|
| 1H,4H,5H-Benzo[g]indazole |
1H,4H,5H-苯并[G]吲唑 |
24445-06-5 |
详细
|
| 2,7-Di-tert-butyl-9,9-diMethylxanthene |
2,7-二叔丁基-9,9-二甲基氧杂蒽 |
130525-41-6 |
详细
|
| Etokimab |
ETOKIMAB (艾托奇单抗 ) |
2022981-44-6 |
详细
|
| Cendakimab |
CENDAKIMAB (申达奇单抗 ) |
2151032-62-9 |
详细
|
| Ieramilimab |
埃拉利单抗 |
2137049-37-5 |
详细
|
| di(pyridin-3-yl)amine |
|
1915-41-9 |
详细
|
| Acetylcysteine Impurity 68 |
乙酰半胱氨酸杂质68 |
74562-18-8 |
详细
|
| 4'-AMINO-2,2':6',2''-TERPYRIDINE |
[2,2':6',2''-三联吡啶]-4'-胺 |
193944-66-0 |
详细
|
| Glenzocimab |
GLENZOCIMAB (格仑西单抗 ) |
2101829-58-5 |
详细
|
| Research Grade Relfovetmab |
RELFOVETMAB (瑞弗维单抗 ) |
2171034-70-9 |
详细
|
| Disitamab |
DISITAMAB (迪西妥单抗 ) |
2185868-98-6 |
详细
|
| 6,6''-dimethyl-2,2':6',2''-terpyridine |
|
33777-92-3 |
详细
|
| Pyridinium, 4-(9-anthracenyl)-2-fluoro-1-methyl-, iodide (1:1) |
|
2376179-18-7 |
详细
|
| Momelotinib |
莫洛替尼 |
1056634-68-4 |
详细
|
| Ethyl 6-mercaptopyridazine-3-carboxylate |
Ethyl 6-mercaptopyridazine-3-carboxylate |
176658-62-1 |
详细
|
| 3,3'-Bithiophene |
3,3'-双噻吩 |
3172-56-3 |
详细
|
| Teclistamab |
TECLISTAMAB (特立妥单抗 ) |
2119595-80-9 |
详细
|
| Nimacimab |
NIMACIMAB (尼迈西单抗 ) |
2098636-09-8 |
详细
|
| Nidanilimab |
NIDANILIMAB (尼达利单抗 ) |
2171061-85-9 |
详细
|
| Cosibelimab |
COSIBELIMAB (柯希利单抗 ) |
2216751-26-5 |
详细
|
| HS-10352 Impurity D |
HS-10352杂质D |
2276229-34-4 |
详细
|
| 5''-Bromo-2,2':5',2''-terthiophene-5-carboxaldehyde |
5-溴-5'-甲酰基-2,2':5'2'-三噻吩 |
161726-69-8 |
详细
|
| 4-Hydrazinobenzoic Acid-d4 Hydrochloride |
4-Hydrazinobenzoic Acid-d4 Hydrochloride |
1246816-67-0 |
详细
|
| 4-chloro-2,6-dimethylquinazoline |
4-氯-2,6-二甲基喹唑啉 |
1429782-21-7 |
详细
|
| Tri(pyridin-4-yl)amine |
三(4-吡啶基)胺 |
153467-50-6 |
详细
|
| 3,6-Di(pyridin-4-yl)-9H-carbazole |
3,6-二(吡啶-4-基)-9H-咔唑 |
1446275-54-2 |
详细
|
| Naxitamab |
NAXITAMAB (那昔妥单抗 ) |
1879925-92-4 |
详细
|
| Balstilimab |
BALSTILIMAB (巴替利单抗 ) |
2230167-06-1 |
详细
|
| Plamotamab |
PLAMOTAMAB (帕拉莫妥单抗 ) |
2138442-31-4 |
详细
|
| 2,2';6',2'']Terpyridine-6,6''-dicarboxylic acid |
[2,2':6',2''-三联吡啶]-6,6''-二羧酸 |
149982-11-6 |
详细
|
| 4-(4-pyridin-4-ylbutyl)pyridine |
1,4-二(吡啶-4-基)丁烷 |
2029-58-5 |
详细
|
| Cobolimab |
COBOLIMAB (考伯利单抗 ) |
2022215-65-0 |
详细
|
| Elipovimab |
ELIPOVIMAB (依帕韦单抗 ) |
2101210-43-7 |
详细
|
| Garadacimab |
GARADACIMAB (加达西单抗 ) |
2162134-62-3 |
详细
|
| Envafolimab |
ENVAFOLIMAB (恩弗利单抗 ) |
2102192-68-5 |
详细
|
| Avdoralimab |
AVDORALIMAB (艾朵利单抗 ) |
2226393-85-5 |
详细
|
| 5,5'-Bi-1H-benzotriazole (8CI,9CI) |
1H,1'H-5,5'-BIBENZO[D][1,2,3]TRIAZOLE |
15805-13-7 |
详细
|
| Benzoic acid, 4-bromo-2,3,5,6-tetramethyl-, methyl ester |
4-溴-2,3,5,6-四甲基苯甲酸甲酯 |
28195-39-3 |
详细
|
| 1,3,6,8-Tetraphenylpyrene |
1,3,6,8-四苯基芘 |
13638-82-9 |
详细
|
| 4-Chloro-6-methoxymethyl-2-phenylpyrimidine |
4-氯-6-(甲氧基甲基)-2-苯基嘧啶 |
325685-59-4 |
详细
|
| 9,10-Di(pyridin-4-yl)anthracene |
9,10-二(4-吡啶基)蒽 |
194861-72-8 |
详细
|
| 3,6-Dibromo-9-ethyl-9H-carbazole |
3,6-二溴-9-乙基咔唑 |
33255-13-9 |
详细
|
| Semorinemab |
SEMORINEMAB (西瑞奈单抗 ) |
2159141-27-0 |
详细
|
| Research Grade Quetmolimab |
QUETMOLIMAB (奎莫利单抗 ) |
2084037-83-0 |
详细
|
| 4'-hydroxy-[1,1'-biphenyl]-3-carbaldehyde |
|
28314-95-5 |
详细
|
| 4',4,4''-TRIMETHYL-2,2':6',2''-TERPYRIDINE |
4,4',4-三甲基-2,2':6',2-三联吡啶 |
33354-75-5 |
详细
|
| triphenylene-1,5,9-triamine |
苯并菲-1,5,9-三胺 |
371786-11-7 |
详细
|
| 2,3,4,5,6-pentaiodobenzoic acid |
五碘苯甲酸 |
64385-02-0 |
详细
|
| Ethanamine, 2-[[2-(ethylthio)ethyl]thio]-N-[2-[[2-(ethylthio)ethyl]thio]ethyl]- |
3,6,12,15-四硫杂-9-氮杂十七烷 |
219658-99-8 |
详细
|
| 2,5-di(pyridin-2-yl)-1H-pyrrole |
2,5-(2-吡啶基)吡咯 |
60779-56-1 |
详细
|
| Mezagitamab |
MEZAGITAMAB (迈泽妥单抗 ) |
2227490-52-8 |
详细
|
| Vofatamab |
VOFATAMAB (沃凡妥单抗 ) |
1312305-12-6 |
详细
|
| Zalifrelimab |
ZALIFRELIMAB (泽弗利单抗 ) |
2148321-69-9 |
详细
|
| Vibecotamab |
VIBECOTAMAB (维克妥单抗 ) |
2138442-13-2 |
详细
|
| Astegolimab |
ASTEGOLIMAB (艾特利单抗 ) |
2173054-79-8 |
详细
|
| 2,5-Cyclohexadiene-1,4-dione, 2-[(1-methylethyl)amino]-5-(phenylamino)- |
2-[(1-甲基乙基)氨基]-5-(苯胺)-2,5-环己二烯-1,4-二酮 |
68054-73-9 |
详细
|
| 2,5-Cyclohexadiene-1,4-dione, 2,5-bis[(2-methylphenyl)amino]- |
2,5-双(邻甲苯氨基)环己-2,5-二烯-1,4-二酮 |
252950-56-4 |
详细
|
| 4-Chloro-6-(methoxymethyl)-2-(pyridin-3-yl)pyrimidine |
2-(3-吡啶基)-4-氯-6-甲氧甲基嘧啶 |
339279-00-4 |
详细
|
| 1H-1,2,4-TRIAZOLE,3,5-BIS(TRIFLUOROMETHYL)- |
1H-1,2,4-TRIAZOLE,3,5-BIS(TRIFLUOROMETHYL)- |
709-62-6 |
详细
|
| Benzaldehyde, 4,4',4''-phosphinidynetris- |
三(四苯甲醛基)磷 |
67753-41-7 |
详细
|
| 1,4-Benzenedicarboxylic acid, 2,3-difluoro- |
2,3-二氟对苯二甲酸 |
1220509-29-4 |
详细
|
| Gancotamab |
Gancotamab |
1509928-00-0 |
详细
|
| Levilimab |
LEVILIMAB (乐维利单抗 ) |
2035008-70-7 |
详细
|
| Volagidemab |
VOLAGIDEMAB (沃拉德单抗 ) |
1233956-13-2 |
详细
|
| Research Grade Avizakimab |
艾维奇单抗 |
2229685-51-0 |
详细
|
| 2,5-Cyclohexadiene-1,4-dione, 2-[(1,3-dimethylbutyl)amino]-5-(phenylamino)- |
2-((4-METHYLPENTAN-2-YL)AMINO)-5-(PHENYLAMINO)CYCLOHEXA-2,5-DIENE-1,4-DIONE |
2754428-18-5 |
详细
|
| 4,4'-bithiazole]-2,2'-diamine dihydrobromide |
|
854455-31-5 |
详细
|
| Amikacin |
阿米卡星 |
37517-28-5 |
详细
|
| racFTY720 Phosphate |
2-氨基-2-(羟基甲基)-4-(4-辛基苯基)丁基磷酸二氢酯 |
402615-91-2 |
详细
|
| 1,3-BIS(2-HYDROXY-4-DIETHYLAMINO-PHENYL)-2-OXO-CYCLOBUTENYLIUM-4-OLAT |
2,4-双[4-(二乙氨基)-2-羟基苯基]方酸 |
68842-66-0 |
详细
|
| Tetrabromo-thieno[3,2-b]thiophene |
四溴噻吩并[3,2-B]噻吩 |
124638-53-5 |
详细
|
| Benzamidoxime |
苯甲酰胺肟 |
613-92-3 |
详细
|
| Benzene, 1,1'-(1,2-ethynediyl)bis[3,5-dibromo- |
1,2-二[3,5-二(溴苯基)]乙炔 |
448895-60-1 |
详细
|
| 1,2,4,5-TETRAIODOBENZENE |
1,2,4,5-四碘苯 |
636-31-7 |
详细
|
| Pozelimab |
POZELIMAB (帕泽利单抗 ) |
2096328-94-6 |
详细
|
| Tamrintamab |
TAMRINTAMAB (他林妥单抗 ) |
2148325-59-9 |
详细
|
| Bedinvetmab |
BEDINVETMAB (贝汀维单抗 ) |
2171034-69-6 |
详细
|
| Cinpanemab |
CINPANEMAB (辛帕奈单抗 ) |
2094516-02-4 |
详细
|
| Benzoic acid, 4-[[6-[(1-oxo-2-propen-1-yl)oxy]hexyl]oxy]-, 4-[[6-[(1-oxo-2-propen-1-yl)oxy]hexyl]oxy]phenyl ester |
BENZOIC ACID, 4-[[6-[(1-OXO-2-PROPEN-1-YL)OXY]HEXYL]OXY]-, 4-[[6-[(1-OXO-2-PROPEN-1-YL)OXY]HEXYL]OXY]PHENYL ESTER |
151464-39-0 |
详细
|
| 1H-1,2,4-Triazole,1-acetyl-(6CI,7CI,8CI,9CI) |
(6CI,7CI,8CI,9CI)-1-乙酰基-1H-1,2,4-噻唑 |
15625-88-4 |
详细
|
| 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diamine, 3-iodo |
1H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6-DIAMINE, 3-IODO |
398117-44-7 |
详细
|
| 1-Boc-2-(cyanoMethyl)pyrrolidine |
N-BOC-2-氰甲基吡咯烷 |
1092352-11-8 |
详细
|
| N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine |
3,6-(二苯胺基)咔唑 |
608527-58-8 |
详细
|
| Tris(4-bromophenyl)phosphane |
三(4-溴苯基)膦 |
29949-81-3 |
详细
|
| Tidutamab |
TIDUTAMAB (泰妥单抗 ) |
2148354-90-7 |
详细
|
| Atoltivimab |
ATOLTIVIMAB (阿替韦单抗 ) |
2135632-29-8 |
详细
|
| Fianlimab |
FIANLIMAB (弗安利单抗 ) |
2126132-98-5 |
详细
|
| Benzene, 1-[(1E)-2-phenylethenyl]-4-(2-phenylethynyl)- |
1-(反式-2-苯基乙烯基)-4-(苯基乙炔基)苯 |
173035-17-1 |
详细
|
| 2,5-Cyclohexadiene-1,4-dione, 2-(cyclohexylamino)-5-(phenylamino)- |
2-(环己基氨基)-5-(苯基氨基)环己基-2,5-二烯-1,4-二酮 |
68054-78-4 |
详细
|
| 4-(pyridin-4-ylmethyl)pyridine |
4,4'-dipyridylmethane |
60776-05-8 |
详细
|
| Pyridine, 4,4'-(2,5-dibromo-1,4-phenylene)bis |
Pyridine, 4,4'-(2,5-dibromo-1,4-phenylene)bis- |
2020402-43-9 |
详细
|
| 2-(4-(Pyridin-4-yl)phenyl)acetonitrile |
2-(4-吡啶-4-基苯基)乙腈 |
112170-33-9 |
详细
|
| 6,6'-dinitro-diphenic acid diethyl ester |
6,6'-二硝基-联苯二甲酸二乙酯 |
200116-21-8 |
详细
|
| 1,3,5-Benzenetricarboxylic acid, 1,3,5-tri-3-pyridinyl ester |
|
1092649-22-3 |
详细
|
| 3,3'-Bi-1,2,4-oxadiazole]-5,5'-dimethanol |
3,3'-联(1,2,4-噁二唑)-5,5'-二甲醇 |
2241022-97-7 |
详细
|